Ágnes Balogh

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2019 · 3.6K citations · Full text

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

Kim Margolin, Marc S. Ernstoff, Omid Hamid et al. · The Lancet Oncology · 2012 · 1.1K citations

Neuro-oncology, Brain Metastases, Medicine +7

Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer

Yung‐Jue Bang, Yeul Hong Kim, Jin Won Kim et al. · Clinical Cancer Research · 2017 · 138 citations · Full text

A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.

G Kéri, J. Érchegyi, Anikó Horváth et al. · Proceedings of the National Academy of Sciences · 1996 · 97 citations

Tumor Biology, Oncology, Tumor-selective Somatostatin Analog +14

Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204).

Hussein Tawbi, Peter Forsyth, F. Stephen Hodi et al. · Journal of Clinical Oncology · 2019 · 82 citations

Neuro-oncology, Neurological Assessment, Medicine +14